about
Pharmacological treatment options for mast cell activation diseaseClinical presentation and management practice of systemic mastocytosis. A survey on 460 Italian patients.Determination of plasma heparin level improves identification of systemic mast cell activation diseaseA French National Survey on Clotting Disorders in Mastocytosis.Epidemiology of MPN: what do we know?Hymenoptera Anaphylaxis and C-kit Mutations: An Unexpected Association.Mastocytosis: the puzzling clinical spectrum and challenging diagnostic aspects of an enigmatic disease.Prevalence, pathogenesis, and treatment options for mastocytosis-related osteoporosis.Often seen, rarely recognized: mast cell activation disease--a guide to diagnosis and therapeutic options.Risk of solid cancer, cardiovascular disease, anaphylaxis, osteoporosis and fractures in patients with systemic mastocytosis: A nationwide population-based study.A child with mastocytosis and lymphomatoid papulosisTargeted Treatment Options in Mastocytosis.Abnormal bone marrow histopathology in paediatric mastocytosis.Risk of solid cancer in patients with mast cell activation syndrome: Results from Germany and USA.Midostaurin treatment in FLT3-mutated acute myeloid leukemia and systemic mastocytosis.Omalizumab prevents anaphylaxis and improves symptoms in systemic mastocytosis: Efficacy and safety observations.Mastocytosis: a case series of 107 consecutive patients.KIT D816V- chronic myelomonocytic leukemia progressing to KIT D816V+ associated to mast cell leukemia responding to allogeneic hematopoietic cell transplantation.Natural history and treatment of cutaneous and systemic mastocytosis.Prevalence triggers and clinical severity associated with anaphylaxis at a tertiary care facility in Saudi Arabia: A cross-sectional study
P2860
Q26748784-BE4D9141-8FF3-4C45-8FF0-79F6C18F8C61Q33431360-B0348150-C6CD-476E-817F-7C21D70BCF18Q35536695-F70ACAC3-2D7F-489D-9B0E-CBF11B3C774CQ36195456-24DB8634-D8D7-4CC1-952F-A9536C9F81D8Q38240406-DE4AD79A-92D3-447F-8665-3C209C2E2DFCQ38543373-67124765-630F-4419-A627-435A5EFD798AQ38582624-CCDA7DA3-67DD-499B-84FF-6637A21AE055Q38739710-B0AF1C72-81CC-40CD-A2CA-1B4321B46EB0Q38788064-601CC5B8-842E-40B6-A45E-8CDA1A6D5136Q40533819-2CCCE56C-E88B-4197-B4C0-7FC0B774F8ABQ40981597-25DC7F21-CE5E-470B-AA21-EA569C7B07F9Q41061871-A9DA4CB1-1F96-4E58-B88F-5B5406DCD2A9Q41645585-31AF321D-0276-4CE8-8E46-1607E044B12DQ47094811-31717A85-99FD-42E9-9DF6-2479F036FBC9Q47727992-6770A25A-D1DD-4005-80A4-37B4E77F7A60Q48199854-1A0727E7-260B-401E-994D-8674A1D83E14Q48267049-050465E0-06D2-4FDC-939C-83660A74DBB2Q48277701-B8E29C6B-E5C8-48B7-A968-691126DD75F6Q52760297-8276FE2B-53AD-4B50-BB1A-5544489BA1F4Q58801979-E1C96A00-4ED2-46BD-9FB6-EB155429A55F
P2860
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Epidemiology of systemic mastocytosis in Denmark.
@en
Epidemiology of systemic mastocytosis in Denmark.
@nl
type
label
Epidemiology of systemic mastocytosis in Denmark.
@en
Epidemiology of systemic mastocytosis in Denmark.
@nl
prefLabel
Epidemiology of systemic mastocytosis in Denmark.
@en
Epidemiology of systemic mastocytosis in Denmark.
@nl
P2093
P2860
P50
P356
P1476
Epidemiology of systemic mastocytosis in Denmark
@en
P2093
Hanne Vestergaard
Jon P Fryzek
Sigurd Broesby-Olsen
Stine Skovbo
Thomas Kristensen
P2860
P304
P356
10.1111/BJH.12916
P407
P577
2014-04-25T00:00:00Z